Teradyne (TER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
Teradyne (TER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Cathie Wood has a $722 million reason to pay attention to the latest move in Teradyne, Inc.. Her funds hold about 2.36 million shares, a position worth roughly $722 million and over 5% of the portfolio, with an average entry price near $87. That conviction has already paid off. The stock surged roughly 350% from $65.77 in April 2025 to a peak of $422.11 in April 2026 — before pulling back sharply in recent sessions. Now, the dip is back in focus. From Breakout To Pullback After an extended run,
As you might know, Teradyne, Inc. ( NASDAQ:TER ) just kicked off its latest first-quarter results with some very strong...
Investors are treating the recent dip in this AI-focused company as a buying opportunity today.
Teradyne's (TER) results reflect an "expectations issue" rather than a miss, as investor optimism ar
TER, ABBNY and KFRC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 30th, 2026.
Investing.com -- Shares in Teradyne jumped more than 6% in premarket trading Thursday after the stock received an upgrade at JPMorgan, with the bank’s analysts flagging an attractive entry point following a nearly 20% post-earnings selloff.
Meta downgraded, Qualcomm upgraded: Wall Street's top analyst calls
Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices except the Nasdaq end lower, with the Nasdaq closing virtually unchanged at 24,603, up 0.04%. The combination of soaring oil prices, the Federal Reserve keeping interest rates unchanged for the third straight meeting, and bogged-down ... Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok